Citadel Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-878,300
| Closed | -$74.6M | – | 10612 |
|
|
2019
Q4 | $74.6M | Sell |
878,300
-10,600
| -1% | -$707K | 0.03% | 544 |
|
|
2019
Q3 | $44.4M | Buy |
888,900
+625,700
| +238% | +$25M | 0.02% | 826 |
|
|
2019
Q2 | $9.6M | Buy |
263,200
+34,800
| +15% | +$1.14M | ﹤0.01% | 2228 |
|
|
2019
Q1 | $6.38M | Buy |
228,400
+92,300
| +68% | +$2.18M | ﹤0.01% | 2646 |
|
|
2018
Q4 | $2.6M | Buy |
136,100
+14,700
| +12% | +$342K | ﹤0.01% | 3735 |
|
|
2018
Q3 | $3.63M | Buy |
121,400
+94,200
| +346% | +$3.55M | ﹤0.01% | 3440 |
|
|
2018
Q2 | $998K | Sell |
27,200
-28,100
| -51% | -$913K | ﹤0.01% | 5215 |
|
|
2018
Q1 | $1.82M | Buy |
55,300
+7,400
| +15% | +$231K | ﹤0.01% | 3880 |
|
|
2017
Q4 | $1.31M | Sell |
47,900
-8,500
| -15% | -$262K | ﹤0.01% | 4258 |
|
|
2017
Q3 | $2.09M | Sell |
56,400
-29,500
| -34% | -$1.09M | ﹤0.01% | 3360 |
|
|
2017
Q2 | $3.27M | Sell |
85,900
-22,000
| -20% | -$980K | ﹤0.01% | 2574 |
|
|
2017
Q1 | $5.28M | Buy |
107,900
+54,700
| +103% | +$2.49M | ﹤0.01% | 1989 |
|
|
2016
Q4 | $1.81M | Sell |
53,200
-3,800
| -7% | -$135K | ﹤0.01% | 3076 |
|
|
2016
Q3 | $2.15M | Buy |
57,000
+13,900
| +32% | +$524K | ﹤0.01% | 2890 |
|
|
2016
Q2 | $1.45M | Buy |
43,100
+19,000
| +79% | +$670K | ﹤0.01% | 3107 |
|
|
2016
Q1 | $766K | Sell |
24,100
-193,800
| -89% | -$6.33M | ﹤0.01% | 3810 |
|
|
2015
Q4 | $8.14M | Buy |
217,900
+165,300
| +314% | +$6.25M | 0.01% | 1434 |
|
|
2015
Q3 | $2M | Buy |
52,600
+22,600
| +75% | +$793K | ﹤0.01% | 2943 |
|
|
2015
Q2 | $858K | Buy |
30,000
+11,000
| +58% | +$306K | ﹤0.01% | 4176 |
|
|
2015
Q1 | $532K | Buy |
19,000
+10,100
| +113% | +$284K | ﹤0.01% | 4804 |
|
|
2014
Q4 | $246K | Sell |
8,900
-5,800
| -39% | -$144K | ﹤0.01% | 5714 |
|
|
2014
Q3 | $328K | Sell |
14,700
-5,800
| -28% | -$147K | ﹤0.01% | 5154 |
|
|
2014
Q2 | $596K | Sell |
20,500
-4,800
| -19% | -$128K | ﹤0.01% | 4161 |
|
|
2014
Q1 | $719K | Buy |
25,300
+15,900
| +169% | +$526K | ﹤0.01% | 3846 |
|
|
2013
Q4 | $363K | Sell |
9,400
-3,200
| -25% | -$114K | ﹤0.01% | 4408 |
|
|
2013
Q3 | $422K | Sell |
12,600
-4,600
| -27% | -$147K | ﹤0.01% | 3986 |
|
|
2013
Q2 | $529K | Buy |
+17,200
| New | +$575K | ﹤0.01% | 3784 |
|
Other funds holding MDCO
Citadel Advisors's MDCO Position: Q1 2020 in Review
Citadel Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 195,601 shares — an estimated $16.6M sold.
Citadel Advisors first reported a position in MDCO in Q2 2013 and held it in 24 quarters. The position peaked at $27.2M in Q3 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Citadel Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 195,601 Medicines Co shares in Q1 2020, an estimated $16.6M.
- Citadel Advisors first reported a position in Medicines Co in Q2 2013 and held it in 24 quarters.
- Citadel Advisors's Medicines Co position peaked at $27.2M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.